MTOR and coronary artery disorder: The drug eluting stent (DES) with mammalian target of rapamycin (mTOR) inhibitors inducing autophagy has achieved widespread application in the management of CAD, which effectively lower restenosis rate after percutaneous coronary intervention (PCI)29.